Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.86 USD | -1.37% | +2.31% | -27.55% |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.55% | 1.54B | |
-19.60% | 11.03B | |
+52.28% | 3.5B | |
-32.61% | 2.23B | |
-14.31% | 2.16B | |
+31.15% | 1.12B | |
-3.28% | 737M | |
-24.50% | 477M | |
-42.86% | 411M | |
+17.30% | 342M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Insider Sell: Veracyte